| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |